Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II

Clinical trial NCT06015854 · UNKNOWN

Trial details

NCT number: NCT06015854
Sponsor: University Medical Center Groningen
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

CIN3 Cervical Intraepithelial Neoplasia Cervical Intraepithelial Neoplasia Grade 3 HPV 16 Infection

Start date: 2021-03-23
Primary completion: 2024-02-06
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.